Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.81 +0.01 (+1.25%)
At close: Oct 2, 2026 · 4:00 PM EDT

Rani Therapeutics Holdings (RANI) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Rani Therapeutics Holdings (RANI) posted Return on Capital Employed [ROCE] of -72.08% for Q2 2026, up 11.59 percentage points from the prior quarter.

Analysis

Rani Therapeutics Holdings (RANI) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Rani Therapeutics Holdings' Return on Capital Employed [ROCE] came in at -109.59%, up 85.10 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a four-year change of -57.56 percentage points (FY2021 to FY2025).
  • In prior years, Rani Therapeutics Holdings' Return on Capital Employed [ROCE] was -194.69% in FY2024 (-106.54 pp), -88.15% in FY2023 (-31.14 pp), -57.01% in FY2022 (-4.98 pp) and -52.03% in FY2021.
  • The Q2 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] since Q1 2023.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in two of the last five quarters, with an average year-over-year change of -22.52 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q1 2026, with a gain of 416.78 percentage points; the weakest was Q1 2025, with a drop of 350.20 percentage points.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Rani Therapeutics Holdings 151.61 Mn 160.36 Mn - -72.08%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -72.08%
Mar 31, 2026 -83.67%
Dec 31, 2025 -176.45%
Mar 31, 2025 -500.45%
Dec 31, 2024 -263.99%
Sep 30, 2024 -221.12%
Jun 30, 2024 -180.56%
Mar 31, 2024 -150.26%
Dec 31, 2023 -117.64%
Sep 30, 2023 -100.75%
Jun 30, 2023 -81.47%
Mar 31, 2023 -68.17%
Dec 31, 2022 -61.42%
Sep 30, 2022 -59.88%
Jun 30, 2022 -67.74%
Mar 31, 2022 -52.06%
Dec 31, 2021 -40.33%
Sep 30, 2021 -42.38%
API Access

Rani Therapeutics Holdings Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=RANI&period=max&api_key=YOUR_API_KEY